Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aniket Thoke"'
Autor:
Purvish M. Parikh, Gouri Shankar Bhattacharyya, Ghanshyam Biswas, Arvind Krishnamurty, Dinesh Doval, Anil Heroor, Sanjay Sharma, Ramakant Deshpande, Harit Chaturvedi, S. P. Somashekhar, Govind Babu, G. Krishna Reddy, Diptendra Sarkar, Chirag Desai, Hemant Malhotra, Nitesh Rohagi, Ajay Bapna, S. S. Alurkar, Prasad Krishna, S. V.S. Deo, Anurag Shrivastava, Prakash Chitalkar, Saroj Kumar Majumdar, Devanhalli Vijay, Aniket Thoke, K. S. Udupa, Jyoti Bajpai, G. K. Rath, Palanki Satya Dattatreya, Shailesh Bondarde, Shekhar Patil
Publikováno v:
South Asian Journal of Cancer, Vol 10, Iss 04, Pp 213-219 (2021)
Breast cancer is a public health challenge globally as well as in India. Improving outcome and cure requires appropriate biomarker testing to assign risk and plan treatment. Because it is documented that significant ethnic and geographical variations
Externí odkaz:
https://doaj.org/article/d5d88f7cebe44f83bae006ee87b01706
Autor:
Anant Ramaswamy, Vikas Ostwal, Nikhil Pande, Atul Sharma, Shekar Patil, Ravi Thippeswamy, Nikhil Ghadyalpatil, Rakesh Roy, Harish Peshwe, Bhavesh Poladia, Deepan Rajamanickam, Bharat Rangarajan, P R Neelesh Reddy, Vimal Pandita, Ashis Mukherjee, Aniket Thoke, Abhijit Sarkar, C T Satish, H Shashidara, S D Banavali
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 1, Pp 22-26 (2019)
Background: Regorafenib is considered a standard of care as third-line therapy in metastatic colorectal cancers (mCRCs). Materials and Methods: The study was based on a computerized clinical data form sent to oncologists across the country for entry
Externí odkaz:
https://doaj.org/article/7e56f6cbb0db4d42bbd0cb160c123c88
Autor:
Purvish M. Parikh, Gouri Shankar Bhattacharyya, Ghanshyam Biswas, Arvind Krishnamurty, Dinesh Doval, Anil Heroor, Sanjay Sharma, Ramakant Deshpande, Harit Chaturvedi, S. P. Somashekhar, Govind Babu, G. Krishna Reddy, Diptendra Sarkar, Chirag Desai, Hemant Malhotra, Nitesh Rohagi, Ajay Bapna, S. S. Alurkar, Prasad Krishna, S. V.S. Deo, Anurag Shrivastava, Prakash Chitalkar, Saroj Kumar Majumdar, Devanhalli Vijay, Aniket Thoke, K. S. Udupa, Jyoti Bajpai, G. K. Rath, Palanki Satya Dattatreya, Shailesh Bondarde, Shekhar Patil
Publikováno v:
South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 10, Iss 04, Pp 213-219 (2021)
South Asian Journal of Cancer, Vol 10, Iss 04, Pp 213-219 (2021)
Breast cancer is a public health challenge globally as well as in India. Improving outcome and cure requires appropriate biomarker testing to assign risk and plan treatment. Because it is documented that significant ethnic and geographical variations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3e993ebf78e7fdde21a342e9b473f19
https://pubmed.ncbi.nlm.nih.gov/34984198
https://pubmed.ncbi.nlm.nih.gov/34984198
Autor:
Prakash S, S, Rajnish Vasant, Nagarkar, Krishna Chaitanya, Puligundla, Lokesh K, N, Rakesh Reddy, Boya, Ankit Baldevbhai, Patel, Lovenish, Goyal, Aniket, Thoke, Jigar Gordhanbhai, Patel, Ajay Omprakash, Mehta, Ghanshyam Nanubhai, Patel, Mujtaba A, Khan, Imran, Ahmad
Publikováno v:
European Journal of Pharmaceutical Sciences. 176:106248
To evaluate the bioequivalence of a hybrid pegylated liposomal doxorubicin (PLD) hydrochloride injection with reference product Caelyx®.This multicenter, open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2c12657a2a30d194657fbbf3b0bbc62
https://doi.org/10.1016/j.ejps.2022.106248
https://doi.org/10.1016/j.ejps.2022.106248
Autor:
Vikas Ostwal, Atul Sharma, Ashis Mukherjee, Harish Peshwe, Nikhil Pande, Rakesh Roy, Ravi Thippeswamy, N. Ghadyalpatil, Anant Ramaswamy, P R Neelesh Reddy, Shekar Patil, Aniket Thoke, Abhijit Sarkar, Bharat Rangarajan, Bhavesh Poladia, HP Shashidara, Vimal Pandita, C T Satish, S D Banavali, Deepan Rajamanickam
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 1, Pp 22-26 (2019)
South Asian Journal of Cancer
South Asian Journal of Cancer
Background: Regorafenib is considered a standard of care as third-line therapy in metastatic colorectal cancers (mCRCs). Materials and Methods: The study was based on a computerized clinical data form sent to oncologists across the country for entry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd87b1429b9d9a41f7dfd31041c9c203
http://journal.sajc.org/article.asp?issn=2278-330X
http://journal.sajc.org/article.asp?issn=2278-330X